Abstract
Treatment results were investigated in 113 previously untreated patients with clinical Stage I and II (Ann Arbor) non-Hodgkin's lymphoma of the head and neck. Fifty-six Waldeyer's ring, 34 other extranodal sites, and 23 cervical nodal lesions were included. The overall relapse-free survival at 5 years was 41%. Age and Ann Arbor stage influenced relapse-free survival. The results suggested that the tumor cell burden is a fundamental prognostic factor for patients with Waldeyer's ring disease and for patients with only cervical nodal disease. Abdominal relapse was most frequent, followed by generalized relapse. From 1981, patients were randomized in a clinical trial to receive either chemotherapy (cyclophosphamide, vincristine, and prednisone [CVP], five courses) or whole-abdominal irradiation (25 Gy/20 Fr) as an adjuvant therapy. Patients could not tolerate the whole-abdominal irradiation well. A significant improvement in survival has been obtained by adjuvant chemotherapy.
References
Feb 1, 1979·International Journal of Radiation Oncology, Biology, Physics·R W FraserF Buschke
Sep 1, 1978·International Journal of Radiation Oncology, Biology, Physics·Y H KimB Schnitzer
Mar 1, 1975·The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine·D S WongC C Shullenberger
Mar 1, 1975·British Journal of Cancer·L J Peters
Feb 1, 1985·International Journal of Radiation Oncology, Biology, Physics·C Jacobs, R T Hoppe
Jul 15, 1972·British Medical Journal·A BanfiR Zucali
Jan 1, 1972·Cancer·C FreemanS J Cutler
Jan 1, 1983·International Journal of Radiation Oncology, Biology, Physics·J M BurgersM van Glabbekke
Dec 1, 1984·American Journal of Clinical Oncology·J S KongJ A Sullivan
Feb 15, 1980·Cancer·W B MillK O Franssila
Jun 1, 1980·Cancer·L J HeifetzC C Shullenberger
Feb 1, 1980·International Journal of Radiation Oncology, Biology, Physics·S MonfardiniA Lattuada
Dec 1, 1980·Cancer·F CabanillasE J Freireich
May 1, 1982·Cancer·J N LesterC C Shullenberger
Jun 1, 1965·Biometrika·E A GEHAN
Citations
Sep 26, 2000·Cancer·K I Lei, P J Johnson
Sep 1, 1994·European Journal of Cancer. Part B, Oral Oncology·A AvilésA Rosas
Mar 29, 2002·Survey of Ophthalmology·Russell W ReadNarsing A Rao
Oct 26, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R A PopescuM E Hill
Feb 11, 2003·American Journal of Clinical Oncology·Gary M ProulxC C Wang
Jan 1, 1994·Histopathology·D H Wright
Jul 1, 1993·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·M KojimaT Johshita
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·D F NelsonK J Murray
Jan 1, 1991·International Journal of Radiation Oncology, Biology, Physics·J W GoldweinG E Hanks
Nov 1, 1988·International Journal of Radiation Oncology, Biology, Physics·N ShigematsuA Mikata
Apr 1, 1990·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·A W GusenbauerA Brown
Jul 13, 2007·International Journal of Pediatric Otorhinolaryngology·Jong-Lyel RohHyung Nam Moon
Jul 2, 2004·Head & Neck·Gwi Eon KimJoo Hang Kim
Jan 1, 1992·Critical Reviews in Oncology/hematology·M R MirzaL Specht
Sep 1, 1987·Histopathology·J K ChanS T Lo
Jan 5, 2002·Pathology, Research and Practice·M KojimaN Masawa
Jul 15, 1994·Cancer·C D RuijsG J Hordijk
Mar 15, 1990·Cancer·N WollnerP Lieberman
Apr 18, 2008·International Journal of Surgical Pathology·Masaru KojimaShigeo Nakamura
Jan 1, 1990·Acta Oncologica·S HisamitsuJ Horiuchi